Authors: KWA W TSANG V FAIREY RN JACKSON SM ELKHATIB E HARRISON RW KRISTENSEN S

Citation: W. Kwa et al., CLINICAL USE OF ASYMMETRIC COLLIMATORS, International journal of radiation oncology, biology, physics, 37(3), 1997, pp. 705-710

Authors: REECE DE BARNETT MJ SHEPHERD JD HOGGE DE KLASA RJ NANTEL SH SUTHERLAND HJ KLINGEMANN HG FAIREY RN VOSS NJ CONNORS JM OREILLY SE SPINELLI JJ PHILLIPS GL

Citation: De. Reece et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+ -P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY/, Blood, 86(2), 1995, pp. 451-456

Authors: FUNG HC VOSS NJ BARNETT MJ FAIREY RN REECE DE PHILLIPS GL SHEPHERD JD NANTEL SH SUTHERLAND HJ TOZE CL KLINGEMANN HG

Citation: Hc. Fung et al., LOW-DOSE THORACOABDOMINAL IRRADIATION FOR TREATMENT OF ADVANCED CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 1550-1550

Authors: REECE DE CONNERS JM SPINELLI JJ BARNETT MJ FAIREY RN KLINGEMANN HG NANTEL SH OREILLY S SHEPHERD JD SUTHERLAND HJ VOSS N CHAN KW PHILLIPS GL

Citation: De. Reece et al., INTENSIVE THERAPY WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE-PLUS-OR-MINUS-CISPLATIN, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE AFTER COMBINATION CHEMOTHERAPY, Blood, 83(5), 1994, pp. 1193-1199